Novel Corona Virus Research
Novel Corona Virus Research
As we are aware of the fact that novel Corona Virus has been the most dangerous pandemic the World has witnessed till date. Below are few information gathered from WHO.
"Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. WHO is concerned by reports of individuals self-medicating with Chloroquine and causing themselves serious harm.
The current outbreak of coronavirus disease (COVID-19) got reported first from Wuhan, China, on 31 December 2019. Coronavirus disease (COVID-19) is an infectious disease caused by a new virus that had not been previously identified in humans.COVID-19 has been declared as a pandemic by WHO due to the alarming levels of spread and severity. Till date, there is no specific medicine to treat or prevent COVID-19.
In response to the outbreak, there is an urgent need to accelerate development of diagnostics, vaccines, novel therapeutics and re-purposing of drugs for this novel coronavirus. In view of the limited current level of knowledge about the new virus, critical research questions need to be answered urgently, and ways have to be found to fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks. Urgent need to develop safe and effective countermeasures that can be available, accessible and suitable for use in populations most in need. Research is an important integral component of the response to be able to identify key knowledge gaps and research priorities, and thereby accelerate the generation of critical scientific information and the most needed medical products to contribute to the control of2019-nCoV emergency.
To support the preparedness, readiness and response for COVID-19, project proposals are being solicited for developing Diagnostics, Vaccines, Novel Therapeutics, Repurposing of Drugs or any other intervention for control of COVID-19 by Industry/Academia/Industry-Academia participation.
By keeping in view the above criteria, Biomedical Research is accepting novel researches in this field to educate the wold for a better living.
Biomedical Research is an open access journal publishing research/original submissions, reviews, brief reports, case studies, rapid communications, letters to the editor etc. related to basic, experimental and clinical aspects of biomedical research.
You may submit the article to www.scholarscentral.org/submissions/biomedical-research.html or as an email attachment to email@example.com or Biomedicalres@emedsci.com or firstname.lastname@example.org or email@example.com
The Biomedical Research Journal follows highly efficient manuscript tracking system for peer review and article tracking process. Generally, submitted manuscripts are sent to two experienced referees from our panel. The contributor’s may submit names of three qualified reviewers who have had experience in the subject of the submitted manuscript, but are not associated with the same institution(s) as the contributors nor have published manuscripts with the contributors in the past 10 years.